Latest France News

Little Green Pharma Ltd (ASX:LGP) has secured overwhelming shareholder approval from Cannatrek Ltd for its proposed acquisition scheme, advancing the transaction toward Federal Court approval and implementation by early May 2026.

Apollo Minerals Limited has validated significant historical tungsten intercepts up to 5.3% WO3 in unmined areas of its Couflens Project in France, highlighting exploration potential around the Veronique Zone and advancing preparations for further drilling.

Lotus Resources has achieved a key milestone with Orano Chimie-Enrichissement accepting its Kayelekera uranium concentrate, paving the way for first uranium exports in the second quarter of 2026.

KMD Brands Limited has announced plans for a capital raise via placement and AREO, coinciding with its upcoming half-year financial results. The company has requested a trading halt as it finalises the terms.

Little Green Pharma has terminated its planned sale and leaseback of its Western Australian production facility after failing to reach commercial terms, choosing to retain ownership without impacting operations.

Orezone Gold Corporation reported a robust 33% increase in revenue for FY2025, underpinned by higher gold prices and the start of hard rock production at Bomboré. The company also announced a strategic acquisition of the Casa Berardi gold mine in Canada.

Ramsay Health Care’s half-year results reveal a dramatic net profit rebound, driven by prior year impairments and solid growth in Australia and Europe. The company also announced a strategic acquisition and a proposed share distribution.

Nuix Limited has reported robust half-year results for 1H26, highlighted by a 148% increase in Nuix Neo Annualised Contract Value and a significant boost in profitability and cash flow.

Ramsay Health Care is set to simplify its corporate structure by distributing its majority stake in European healthcare provider Ramsay Santé directly to shareholders, enabling focused growth strategies for both entities.

Little Green Pharma has entered a $7.8 million sale and leaseback agreement for its Western Australia production site, aiming to fuel growth in Australia and Europe while maintaining operational control.

Orora Limited reported a statutory profit of $58.9 million for the half-year ended December 2025, driven by operational improvements despite significant restructuring costs. The company declared an interim dividend and announced a fresh share buy-back program.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.